Wave Life Sciences Ltd. (WVE)

PriceLoading quote

Financial charts

Revenue

Net income

Free cash flow

Total cash / debt

CashTotal debt

Financial statements

13 annual periodsNewest to oldest
2025202420232022202120202019201820172016201520142013
Revenue$42.7M$108.3M$113.3M$3.6M$41.0M$20.1M$16.0M$14.4M$3.9M$1.1M$152,000
Research & development$182.8M$159.7M$130.0M$115.9M$121.9M$130.9M$175.4M$134.4M$79.3M$40.8M$9.1M$2.4M$1.9M
Operating expenses$258.1M$218.7M$181.3M$166.4M$168.0M$173.5M$224.3M$173.9M$106.3M$56.8M$19.4M$5.4M$3.6M
Operating income−$215.4M−$110.4M−$68.0M−$162.7M−$127.0M−$153.4M−$208.3M−$159.5M−$102.4M−$55.7M−$19.3M−$5.4M−$3.6M
EBITDAderived−$100.2M−$54.9M−$18.7M−$5.1M−$3.3M
Net income−$204.4M−$97.0M−$57.5M−$161.8M−$122.2M−$149.9M−$193.6M−$146.7M−$102.0M−$55.7M−$19.2M−$5.2M−$3.3M
Basic EPSper diluted share-$1.21-$0.70-$0.54-$2.05-$2.36-$3.82-$5.72-$5.06-$3.85-$2.44-$1.83-$1.34-$1.90
Diluted EPSper diluted share-$1.21-$0.70-$0.54-$2.05-$2.36-$3.82-$5.72-$5.06-$3.85-$2.44-$1.83-$1.34-$1.90

Insider buys & sells

Jul 1, 2024Jun 30, 2026
Buys7$104.90M disclosed value
Sells (SEC code S)62$27.31M disclosed value
69 recent transactions
TransactionInsiderTypeSharesPriceValueOwned after
Mar 30, 2026Form 4RA CAPITAL MANAGEMENT, L.P. +3Director,TenPercentOwnerBuyOrdinary Shares · indirect971.1K$6.50$6.31M26.98M
Mar 27, 2026Form 4RA CAPITAL MANAGEMENT, L.P. +3Director,TenPercentOwnerBuyOrdinary Shares · indirect2.50M$6.43$16.05M26.00M
Mar 26, 2026Form 4RA CAPITAL MANAGEMENT, L.P. +3Director,TenPercentOwnerBuyOrdinary Shares · indirect351.2K$6.38$2.24M23.51M
Mar 26, 2026Form 4RA CAPITAL MANAGEMENT, L.P. +3Director,TenPercentOwnerBuyOrdinary Shares · indirect4.95M$6.06$30.02M23.16M
Feb 26, 2026Form 4 · 10b5-1Francis ChrisSee RemarksSellOrdinary Shares15.3K$15.00$229.4K61.9K